Consistent with this, it was described that MPZL1 stable overexpression led to SRC and SHP2 activation, the former being required for the regulation of migration and invasion of hepatocellular carcinoma cells dependent on cortactin21, which was also previously identified as a GRB2 binding partner35. Here, MPZL1 is linked to hepatocellular carcinoma.